University of Hasanuddin Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Makassar Indonesia (1956)

Organization Overview

First Clinical Trial
2014
NCT01999686
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bumi Herman | Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hasanuddin, Dr. Wahidin Sudirohusodo Hospital, Makasar, Indonesia. | Hasanuddin University

Active Ingredients

Drugs in Phase 4 Trials (4)

dextrose (3 trials)

hyaluronic acid (1 trial)

rillus (1 trial)

sodium chloride (1 trial)

Drugs in Phase 3 Trials (2)

dlbs3233 (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (5)

beta carotene (solatene) (1 trial)

oryza sativa (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

zinc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 4)

Obesity (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Polycystic Ovary Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 11